NewCardio Research Development from 2010 to 2026

NWCI Stock  USD 0.0001  0.00  0.00%   
NewCardio's Research Development is increasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 2.5 M. For the period between 2010 and 2026, NewCardio, Research Development quarterly trend regression had mean deviation of  452,784 and range of 3.8 M. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
4.1 M
Current Value
2.5 M
Quarterly Volatility
827.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 89.26, Dividend Yield of 0.0 or Days Sales Outstanding of 40.43. NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
  
Build AI portfolio with NewCardio Stock
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
The Research Development trend for NewCardio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether NewCardio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest NewCardio's Research Development Growth Pattern

Below is the plot of the Research Development of NewCardio over the last few years. It is NewCardio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewCardio's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

NewCardio Research Development Regression Statistics

Arithmetic Mean3,364,389
Geometric Mean3,096,921
Coefficient Of Variation24.59
Mean Deviation452,784
Median3,585,115
Standard Deviation827,456
Sample Variance684.7B
Range3.8M
R-Value0.31
Mean Square Error659B
R-Squared0.1
Significance0.22
Slope51,202
Total Sum of Squares11T

NewCardio Research Development History

20262.5 M
20254.1 M
20113.6 M
2010369.7 K

About NewCardio Financial Statements

Investors use fundamental indicators, such as NewCardio's Research Development, to determine how well the company is positioned to perform in the future. Although NewCardio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development4.1 M2.5 M

Currently Active Assets on Macroaxis

When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is there potential for Health Care Technology market expansion? Will NewCardio introduce new products? Factors like these will boost the valuation of NewCardio. Anticipated expansion of NewCardio directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
Understanding NewCardio requires distinguishing between market price and book value, where the latter reflects NewCardio's accounting equity. The concept of intrinsic value - what NewCardio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push NewCardio's price substantially above or below its fundamental value.
It's important to distinguish between NewCardio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewCardio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NewCardio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.